Clinical Decision Support System Market by Component (Hardware, Services, and Software), Delivery (On-premise, Cloud Based, and Web Based), Product (Standalone and Integrated), Application (Drug-drug interactions, Drug allergy alerts, Clinical reminders, Clinical guidelines, Drug dosing support & drug shortage, and Others), Interactivity (Active and Passive), End User (Life Sciences, Healthcare Providers, On-Site Clinics, Government, Employers, Health Plans, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026033 | Pages: 100 | Industry: Healthcare IT | Date: Sep 2022 | Type: Global

The market crossed US$ 1.35 billion mark in 2022 and is expected to hit US$ 2.88 billion by 2030, recording a CAGR of 9.9 % during the forecast period.

Hardware segment held the largest share in 2022

The rising demand for quality care integrated with reliable technical solutions and the implementation of government regulations to promote the adoption of HCIT solutions are some of the major factors driving the growth of the market. With the increasing adoption of information systems by hospitals and healthcare institutes, the market is expected to witness a significant growth during the forecast period.  The clinical decision support system comprises of both non-computerized and computerized tools. The hardware segment is expected to pace up with the rising adoption of clinical decision support system among physicians. The core hardware elements comprises of a base or data management layer, inference engine or processing layer, and user interface. Healthcare institution and hospitals must have these hardware present in their premises and they might integrate novel software updates into the same without any additional operational cost. Though the initial cost is higher in setting such installations, but there are no additional cost or expenses after the same. The CDSS tools helps the medical professionals making decisions at the point of care. Such a factor has aided the CDSS market in the recent past and is expected to continue a similar trend over the forecast period.

Within the report, the market is segmented into component, delivery, product, application, interactivity, and geography. By component, the market is further segmented into hardware, services, and software. On the basis of delivery, the market is segmented into on-premise, cloud based, and web-based. By product, the market is categorized into standalone and integrated. By application, the market is divided into drug-drug interactions, drug allergy alerts, clinical reminders, clinical guidelines, drug dosing support, and others. Based on interactivity, the market is divided into active and passive. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

Clinical decision support system is a far-reaching technology that is empowering the growth of healthcare providers.

According to the Centers for Disease Control and Prevention (CDC), clinical decision support systems (CDSS) are advanced programs that analyze data to help healthcare providers in applying evidence-based clinical guidelines at the point of care. CDSS includes a number of tools designed to improve clinical decision-making. Clinical decision support (CDS) can have a significant impact on healthcare safety, quality, efficiency, and effectiveness. Hospitals use CDSSs for various tasks, from generating alert notifications to drug control to ordering tests. For instance, CDSS designed and implemented in Cleveland Clinic provides a point-of-care alert to healthcare physicians when a patient’s record matches clinical trial criteria. The alert prompts the user to complete a form which establishes eligibility and consent-to-contact, forwards the patient’s chart to the coordinator, and prints a clinical trial patient information sheet.

Clinical reminders in application segment held the largest share in 2022

Clinical reminders are intended to improve clinical care by reminding physicians or nurses in real-time during patient exams to take a set of recommended actions. Reminders assist clinical decision-making and improve documentation and follow-up by allowing providers to easily view when certain tests or evaluations are performed and track and document when care has been delivered. Clinical reminders are designed to reduce the likelihood that an aspect of care will "fall through the cracks" during a busy exam and ensure that care is well-documented so that the range of health care providers interacting with each patient will have full access to the patient history, and increase standardization across patient exams.

Get more information on this report :

Recent strategic developments in Clinical Decision Support System Market

The clinical decision support system market has undergone several significant developments, and a few of these have been mentioned below:

  • In April 2021, Change Healthcare revealed InterQual 2021, the newest version of the corporation’s flagship CDS solution. This release features four innovative Medicare criteria elements along with a substantial amount of evidence-based content updates and enhancements, comprising new guidance for COVID-19 patients, addressing social factors of health, and suitable usage of telehealth.
  • In 2021, (GHA) announced plans to expand Allscripts Sunrise electronic health records (EHR) across Victoria, Australia of Gippsland.
  • In 2022, Allscripts (US) made an agreement to sell Constellation (Canada), the net assets of Allscripts Hospitals and the Large Physician Practices business segment. The Hospitals and Large Physician Practices business segment includes the Sunrise, Paragon, Allscripts TouchWorks, Allscripts Opal, STAR, HealthQuest, and dbMotion solutions.

The clinical decision support system market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Cerner Corporation, Change Healthcare, Epic Systems, EPSi/Allscripts, Nuance, MEDITECH, Philips Healthcare, Wolters Kluwer N.V., Siemens Healthineers, McKesson Corporation, IBM Watson Health, Stanson Health, Merative are among the prominent players operating in the market.

Target audience for the report:

  • Hardware companies
  • Solution Providers
  • Hospitals and clinics
  • Healthcare payers
  • Healthcare institutes
  • Government bodies, such as regulating authorities and policy makers
  • Clinical Laboratories

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Component:
    • Hardware
    • Software
    • Services
  • Delivery
    • On-premise
    • Cloud-based
    • Web-based
  • Product:
    • Standalone
    • Integrated
  • Application:
    • Drug-drug interactions
    • Drug allergy alerts
    • Clinical reminders
    • Clinical guidelines
    • Drug dosing support
    • Others
  • Interactivity:
    • Active
    • Passive
  • Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • The Middle East & Africa
  • Companies profiled
    • Cerner Corporation
    • Change Healthcare
    • Epic Systems
    • MEDITECH
    • Philips Healthcare
    • Wolters Kluwer N.V.
    • Siemens Healthineers
    • McKesson Corporation
    • IBM Watson Health
    • Stanson Health
 

Companies profiled
- Cerner Corporation
- Change Healthcare
- Epic Systems
- MEDITECH
- Philips Healthcare
- Wolters Kluwer N.V.
- Siemens Healthineers
- McKesson Corporation
- IBM Watson Health
- Stanson Health

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500